文献速递乳腺MR

术前动态对比增强磁共振成像的药代动力学定量参数及其直方图和纹理特征鉴别乳腺癌Luminal A与Luminal B分子亚型

Differentiation between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
PubMed 文献 · Acad Radiol · 2020-01-01

回顾性分析94例经组织病理学证实的乳腺癌患者术前DCE-MRI数据,提取Ktrans、Kep、Ve及其直方图和纹理特征,比较Luminal A与B组、HER2阳性与阴性Luminal B组、淋巴结转移阳性与阴性组间的差异。Luminal B组的Ktrans、Kep、Ve最大值及Ve均值和90百分位值显著高于Luminal A组,仅Ktrans偏度在两组间有显著差异;HER2阳性Luminal B组的Ktrans直方图特征均高于HER2阴性Luminal B组;淋巴结转移阳性与阴性组间无参数差异。结论认为DCE-MRI药代动力学定量参数及直方图纹理特征与乳腺癌分子亚型相关,可能作为鉴别Luminal A与B的潜在影像生物标志物。

要点

  • Luminal B组Ktrans、Kep、Ve最大值及Ve均值、90百分位值显著高于Luminal A组。
  • 纹理特征中仅Ktrans偏度在Luminal A与B组间有显著差异。
  • HER2阳性Luminal B组Ktrans所有直方图特征均高于HER2阴性Luminal B组。

核心结论

  • DCE-MRI药代动力学定量参数及直方图纹理特征与乳腺癌分子亚型相关,可能作为鉴别Luminal A与Luminal B的潜在影像生物标志物。

研究设计与样本

  • 回顾性分析94例经组织病理学证实的乳腺癌患者,获取术前DCE-MRI的药代动力学定量参数Ktrans、Kep、Ve及其直方图和纹理特征。

诊断标准与关键数值

  • Luminal B组Ktrans、Kep、Ve最大值及Ve均值、90百分位值显著高于Luminal A组;仅Ktrans偏度在两组间有显著差异;HER2阳性Luminal B组Ktrans所有直方图特征均高于HER2阴性Luminal B组;淋巴结转移阳性与阴性组间无参数差异。

临床应用与阅片要点

  • 作者认为DCE-MRI药代动力学定量参数及直方图纹理特征可能作为鉴别Luminal A与Luminal B分子亚型的潜在影像生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of the present study was to use pharmacokinetic quantitative parameters with histogram and texture features on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to differentiate between the luminal A and luminal B molecular subtypes of breast cancer.

METHODS: We retrospectively reviewed the data of 94 patients with histopathologically proven breast cancer. The pharmacokinetic quantitative parameters (Ktrans, Kep, and Ve) with their corresponding histogram and texture features based on preoperative DCE-MRI were obtained. The parameters were compared using the Mann-Whitney U-test between the luminal A and luminal B groups, the human epidermal growth factor receptor-2 (HER2)-positive luminal B and HER2-negative luminal B groups, and the lymph node metastasis (LNM)-positive and LNM-negative groups. Receiver operating characteristic curves were generated for parameters that presented significant between-group differences.

RESULTS: The maximum values of Ktrans, Kep, and Ve, and the mean and 90th percentile values of Ve were significantly higher in the luminal B group than in the luminal A group. Among the texture features, only skewness of Ktrans significantly differed between the luminal A and B groups. All histogram features of Ktrans were higher in the HER2-positive luminal B group than in the HER2-negative luminal B group. However, no parameter differed between the LNM-positive and LNM-negative groups.

CONCLUSION: Pharmacokinetic quantitative parameters with histogram and texture features obtained from DCE-MRI are associated with the molecular subtypes of breast cancer, and may serve as potential imaging biomarkers to differentiate between the luminal A and luminal B molecular subtypes.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Luo HB, Du MY, Liu YY, et al. Differentiation between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Acad Radiol. 2020. PMID: 31151899. doi:10.1016/j.acra.2019.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。